Vimarsana
Biggest News Aggregation in the World

Bluebird Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bluebird Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bluebird Ventures Today - Breaking & Trending Today

Foresight Diagnostics Raises $58.75M in Series B Financing - Vimarsana News

Foresight Diagnostics Raises $58.75M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Kriya Therapeutics Raises $270M in Series C Financing - Vimarsana News

Kriya Therapeutics Raises $270M in Series C Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Durham's Kriya Adds $270M to Coffers, Bringing Total Raised to Date to $450.5M for Gene Therapies - Vimarsana News

Durham's Kriya Adds $270M to Coffers, Bringing Total Raised to Date to $450.5M for Gene Therapies

Durham's Kriya Therapeutics just added $270 million to its coffers, bringing its total raised to date to roughly $450 million for novel gene therapies

Leyden Laboratories Closes $140M Series B Financing - Vimarsana News

Leyden Laboratories Closes $140M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Following Janssen flu deal, Leyden Labs gets $140M led by Casdin Capital and GV - Vimarsana News

Following Janssen flu deal, Leyden Labs gets $140M led by Casdin Capital and GV

Leyden Labs is developing nasal spray medicines to prevent respiratory viral infections. The company’s Series B round of funding follows a licensing deal that gives the biotech rights to a Janssen antibody designed to address the two types of influenza that cause seasonal flu.